Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI known ✓ | P41743 | 1/20 | 0.53 |
| ▸ | TBXAS1 | P24557 | 12/20 | 0.92 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | QPCT | Q16769 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4913930 | 0.98 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL2831076 | 0.98 | TBXAS1 (0.89) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL4361596 | 0.98 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL17273534 | 0.98 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL2994509 | 0.98 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL25395768 | 0.98 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL556832 | 0.98 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL22026958 | 0.98 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL22027279 | 0.98 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI | |
| Hydrochloric Acid SCHEMBL28550671 | 0.98 | TBXAS1 (0.96) | TBXAS1KDM4ELMNAQPCTPRKCI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121754720-B | Self-drying gel and preparation method and application thereof | 南京师范大学 | 2026-05-12 | — | — | CN | claimed |
| CN-116081601-B | Carbon quantum dot electrolyte solution for photocathode reduction system | 陕西师范大学 | 2025-02-25 | — | — | CN | claimed |
| CN-117903365-A | Ionic gel for detecting freshness of food and preparation method thereof | 中国科学院大连化学物理研究所 | 2024-04-19 | — | — | CN | claimed |
| CN-116082131-B | Method for synthesizing 1-indanone compound by one-pot method | 苏州华道生物药业股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117756973-A | Extreme temperature resistant sensing organic ionic gel and preparation method and application thereof | 北京工商大学 | 2024-03-26 | — | — | CN | claimed |
| CN-112724107-B | Preparation method of alpha-oxo-2-furyl acetic acid and ester thereof | 南京工业大学 | 2024-01-30 | — | — | CN | claimed |
| WO-2024020209-A2 | GRAPHENE NANORIBBON WITH NANOPORE-BASED SIGNAL DETECTION AND GENETIC SEQUENCING TECHNOLOGY | Acorn Genetics Inc. (US) | 2024-01-25 | — | — | WO | claimed |
| US-20240027395-A1 | Graphene nanoribbon with nanopore-based signal detection and genetic sequencing technology | ACORN GENETICS INC (US) | 2024-01-25 | — | — | US | claimed |
| CN-117209958-A | Epoxy resin composite material and preparation method thereof | 内蒙古赛勒商贸有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-115779884-B | Preparation method of two-dimensional ultrathin bismuth alkene nanosheet material and photocatalytic CO thereof 2 Application of reduction conversion | 江苏大学 | 2023-11-10 | — | — | CN | claimed |
| US-20110124890-A1 | BATCH, SEMI-CONTINUOUS OR CONTINUOUS HYDROCHLORINATIONOF GLYCERIN WITH REDUCED VOLATILE CHLORINATED HYDROCARBON BY-PRODUCTS AND CHLOROACETONE LEVELS | BLUE CUBE IP LLC | 2011-05-26 | — | — | US | claimed |
| US-7928031-B2 | mixture of organic ionic liquids and indium halides, used for electrophilic aromatic substitution reactions, such as alkylation or acylation reactions; catalysis | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2011-04-19 | — | — | US | claimed |
| US-7906690-B2 | Batch, semi-continuous or continuous hydrochlorination of glycerin with reduced volatile chlorinated hydrocarbon by-products and chloracetone levels | DOW GLOBAL TECHNOLOGIES INC. | 2011-03-15 | — | — | US | claimed |
| WO-2010075232-A1 | TUNABLE POLYMER COMPOSITIONS | NOVOMER, INC. (US) | 2010-07-01 | — | — | WO | claimed |
| US-20100148126-A1 | GENOMIC SEQUENCING USING MODIFIED PROTEIN PORES AND IONIC LIQUIDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-06-17 | — | — | US | claimed |
| WO-2010062903-A2 | GENOMIC SEQUENCING USING MODIFIED PROTEIN PORES AND IONIC LIQUIDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-06-03 | — | — | WO | claimed |
| US-20080015369-A1 | Batch, semi-continuous or continuous hydrochlorination of glycerin with reduced volatile chlorinated hydrocarbon by-products and chloracetone levels | BLUE CUBE IP LLC | 2008-01-17 | — | — | US | claimed |
| US-20050054694-A1 | Catalyst comprising indium salt and organic ionic liquid and process for friedel-crafts reactions | QUEEN'S UNIVERSITY OF BELFAST, THE (GB) | 2005-03-10 | — | — | US | claimed |
| EP-1432512-A1 | CATALYST COMPRISING INDIUM SALT AND ORGANIC IONIC LIQUID AND PROCESS FOR FRIEDEL-CRAFTS REACTIONS | The Queen's University of Belfast (GB) | 2004-06-30 | — | — | EP | claimed |
| WO-2003028883-A1 | CATALYST COMPRISING INDIUM SALT AND ORGANIC IONIC LIQUID AND PROCESS FOR FRIEDEL-CRAFTS REACTIONS | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2003-04-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124890-A1 | BATCH, SEMI-CONTINUOUS OR CONTINUOUS HYDROCHLORINATIONOF GLYCERIN WITH REDUCED VOLATILE CHLORINATED HYDROCARBON BY-PRODUCTS AND CHLOROACETONE LEVELS | GK, CHLSN, GLI2 | PRKCI 1513/4885TBXAS1 3610/4885KDM4E 3899/4885 |
| US-20080015369-A1 | Batch, semi-continuous or continuous hydrochlorination of glycerin with reduced volatile chlorinated hydrocarbon by-products and chloracetone levels | GK, GLI2, CHLSN | PRKCI 1274/4885TBXAS1 3537/4885KDM4E 4025/4885 |
| US-20050054694-A1 | Catalyst comprising indium salt and organic ionic liquid and process for friedel-crafts reactions | CEL, KAT5, LEF1 | PRKCI 1202/4885TBXAS1 4354/4885KDM4E 1011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.